AFAP1 and lung carcinoma: Small interfering RNAs (siRNAs) that target RNA molecules via complementary to paired lncRNA sequences exhibited high knockdown effectiveness to lncRNA AFAP1-AS1 in lung cancer cells and reported encouraging anticancer effects both in vitro and in vivo in our study.